The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes.
Open Access
- 1 August 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 133 (2) , 855-862
- https://doi.org/10.4049/jimmunol.133.2.855
Abstract
To evaluate the feasibility of using a monoclonal anti-Fc receptor antibody to alter Fc receptor function in vivo, the disappearance of radiolabeled human serum albumin-rabbit anti-human serum albumin (HSA-anti-HSA) complexes was studied in mice before and after the infusion of 2.4G2, a monoclonal antibody (developed by J. Unkeless). 2.4G2 specifically binds to Fc receptors on mouse macrophages. Under standardized conditions, 6.1% of an i.v. administered dose of anti-HSA was sequestered in the liver of B6/D2J mice. When HSA-anti-HSA complexes were administered, 53.4% were sequestered. If 8 micrograms/g body weight of 2.4G2 was infused i.p. 1.5 hr before HSA-anti-HSA, only 13.7% of the infused complexes were sequestered in the liver. The inhibition in Fc receptor-mediated sequestration produced by this dose of antibody persisted for at least 24 hr. A dose of 1 to 2 micrograms/g was sufficient to inhibit sequestration by 50%. Animals receiving daily injections of 2.4G2 cleared immune complexes from their blood much more slowly than untreated animals. Because 2.4G2 was not cytotoxic to peritoneal macrophages in vitro in the presence of serum, and because comparable inhibition of Fc receptor function was observed in vivo in C5-deficient mice, blockade of function does not depend upon complement-mediated lysis of macrophages. The maximal degree of inhibition of Fc receptor function obtained by using intact 2.4G2 was about twice that observed by using Fab fragments of 2.4G2 to block receptors. In addition to its effect on Fc receptor function, 2.4G2 also had a small but significant inhibitory effect upon the clearance of 125I-labeled heat-aggregated HSA by the mononuclear phagocyte system both in intact and C5-deficient mice. We conclude that 2.4G2 is a potent inhibitor of IgG Fc receptor-mediated immune clearance in vivo.This publication has 8 references indexed in Scilit:
- Immunoglobulin G Fc Receptor-Mediated Clearance in Autoimmune DiseasesAnnals of Internal Medicine, 1983
- REVERSAL OF NEUTROPENIA WITH INTRAVENOUS GAMMA-GLOBULIN IN AUTOIMMUNE NEUTROPENIA OF INFANCY1983
- Sjögren's Syndrome: A Defect in Reticuloendothelial System Fc-Receptor-Specific ClearanceAnnals of Internal Medicine, 1979
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979
- Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus ErythematosusNew England Journal of Medicine, 1979
- STUDIES OF RETICULOENDOTHELIAL FUNCTION IN THE MOUSE WITH MODEL IMMUNE-COMPLEXES .1. SERUM CLEARANCE AND TISSUE UPTAKE IN NORMAL C3H-MICE1979
- Pathophysiology of Immune Hemolytic AnemiaAnnals of Internal Medicine, 1977
- DISAPPEARANCE KINETICS OF SOLUBLE IMMUNE-COMPLEXES PREPARED WITH REDUCED AND ALKYLATED ANTIBODIES AND WITH INTACT ANTIBODIES IN MICE1976